Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option
★★★★★ monitor_heart Health Score: 75/100 · GoodTata Mutual Fund · Equity · Sectoral
₹31.71
AUM: ₹1,455 Cr
NAV updated 15 days ago
Plan
Regular
Option
Growth
Risk
Very High
Expense Ratio
0.98%
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Fund Manager
Rupesh Patel, Sonam Udasi
Inception
Dec 2015
Benchmark
BSE Healthcare Total Return Index
Sharpe Ratio
-0.3
Std Dev (1Y)
12.65%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+5.5%
3m
+14.43%
6m
+10.14%
1y
+10.13%
3y
+23.34%
5y
+15.14%
10y
+14.9%
since inception
+11.55%
rate_review TopFund's Take on TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option holds up reasonably well within the Sectoral category, currently carrying a 3-star rating. It has delivered steady, if unspectacular, returns over a full market cycle. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 75/100.
Cost: At 0.98%, the expense ratio is roughly in line with the Sectoral category average of 1.05% — cost isn't a standout factor either way for this fund.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.3 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 12.65% is fairly typical for actively managed equity funds.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
donut_small Sector Allocation
pie_chart Asset Allocation
info Fund Snapshot
Similar Funds
ICICI Prudential Infrastructure Fund - Direct Plan - Growth
ICICI Prudential Mutual Fund
TATA Digital India Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option
Tata Mutual Fund
TATA Digital India Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option
Tata Mutual Fund
Franklin Build India Fund - Direct - Growth
Franklin Templeton Mutual Fund
UTI Infrastructure Fund-Growth Option- Direct
ICICI Prudential Mutual Fund
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
SBI Mutual Fund
tips_and_updates Tools & Guides for This Fund
Frequently Asked Questions about TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option
The current NAV (Net Asset Value) of TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is ₹31.71. NAV is updated every business day after market close by AMFI.
1Y: 10.13% · 3Y CAGR: 23.34% · 5Y CAGR: 15.14%
The expense ratio is 0.98% per annum — the annual fee deducted from your investment to cover fund management costs.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is managed by Rupesh Patel, Sonam Udasi at Tata Mutual Fund.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is a Very High risk fund. Suitable for aggressive investors with a 5+ year horizon.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is a Sectoral fund. SIP suitability depends on your investment goal and risk profile.
The Assets Under Management (AUM) of TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is ₹1,455 crore as of the latest data.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.